July 29, 2021


Latest online bangla news | bd, world, Sports, photo, video live | Norobotsverification

How effective is the vaccine against the Delta Plus variant? ICMR is taking these steps to know



  • Not enough data to worry about ‘Delta Plus’ pattern
  • The delta variant is believed to be responsible for the second wave in India.
  • Its 40 patients appeared in four states including Maharashtra, Tamil Nadu.

New Delhi
The Delta Plus variant of Corona is now spreading in the country. In such a situation, the question is arising in the minds of people that how effective is the corona vaccine against the delta plus variant. The central government had on Tuesday classified the Delta Plus Covid variant as ‘of concern’. Advisory has been issued by the Central Government to Maharashtra, Kerala, Madhya Pradesh. However, the government says that there is no significant increase in the cases of this variant.

Covid Delta + Variant: About 40 cases of Delta Plus in India so far, the government called it a worry variant of Corona virus
Monitoring the effectiveness of the vaccine
ICMR scientist Dr Samiran Panda said that they are closely monitoring the inactivation ability of the serum of people who have got the Kovid vaccine against the delta-plus variants found from different places. He said the results should come out in a few weeks. Dr. Panda told the Times of India that we are examining the samples received from different places. This will help to find out whether the Kovid-19 vaccine is effective against the new variant or not. He said that we hope that the effectiveness of the vaccine will continue against this new variant as well.

‘Delta Plus, a new form of Kovid surfaced, but there is no danger of third wave’
Don’t mistake the delta variant
Virologist Dr T Jacob John told TOI that as of now, all variants of concern are neutralized by antibodies induced by infection with the “founder variant”. Therefore, the corona vaccine can be estimated to be effective even on Delta-Plus, he said. Dr. Jacob said that there is a need to keep a constant eye on Delta Plus. The mistake we made with Delta should not have happened, he said. The Delta variant was detected in December 2020. This was not followed then due to which the second wave of corona came. He said that there is no need to panic. “Ultimately, we are calling all of these as variants, not ‘strains.

Delta Plus Variant: The third wave of corona will come only from the Delta Plus variant? Know the answers to more such big questions
‘No reason to worry about Delta Plus’
Dr. Shashank Joshi, member of Maharashtra’s Kovid-19 Task Force, says that there is not enough data to worry about the ‘delta plus’ nature of the corona virus. All we need to worry about is that we strictly adhere to COVID friendly behavior by wearing two masks, avoiding overcrowding and getting vaccinated, he tweeted.

What is Delta Plus variant
The Delta Plus variant of Corona is a modified version of the highly contagious Delta variant. Delta is believed to be responsible for the second wave in India. The Delta Plus variant (B.1.617.2.1) is a replacement for the Delta variant (B.1.617.2). A mutation in the spike protein of the delta variant resulted in a delta plus. The virus spreads in the body only through the spike protein. Similar changes have been observed in the spike protein of Delta Plus, the first beta variant detected in South Africa.

40 cases have come to the fore in four states
So far, 40 of its patients have been reported in four states. The four states where this variant has been found are Maharashtra, Madhya Pradesh, Kerala and Tamil Nadu. Only 21 cases have been found in Maharashtra. This variant of the corona virus is said to be a super spreader, which spreads much faster than the rest of the variants. A statement issued by the Ministry of Health said that the Indian SARS Cov-2 Genomics Consortium (INSACOG) had reported that the delta plus form, the ‘currently of concern (VOC)’ form, has a rapid proliferation, lung cells It has features such as strongly binding to the K receptor and a possible reduction in the ‘monoclonal antibody’ response.